Medicare Enrolled
Dr. Mohammad Mobayed, MD
Hematology & Oncology · Rochester Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mobayed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mobayed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mobayed
Dr. Mohammad Mobayed is a hematology & oncology specialist in Rochester Hills, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mobayed performed 2,975 Medicare services across 596 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mobayed received a total of $12,322 from 78 pharmaceutical and/or device companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mobayed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in MI
$12,322 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,975
Medicare services
Top 26% in MI for hematology & oncology
596
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~157 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Monoferric) | 1,600 | $16 | $65 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
418 | $96 | $266 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
364 | $97 | $335 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
160 | $139 | $516 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
128 | $11 | $36 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
112 | $64 | $185 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
42 | $125 | $437 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
40 | $141 | $469 |
| Prolonged inpatient or observation care, each additional 15 minutes This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider. |
25 | $25 | $250 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
22 | $1 | $2 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
19 | $8 | $8 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
17 | $47 | $186 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
17 | $93 | $273 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
11 | $9 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
55.1% high complexity
4.3% medium
40.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,322
Total received (2018-2024)
Avg $1,760/year across 7 years
Top 14% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
405
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,287 (91.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$659 (5.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$376 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,913
2023
$3,267
2022
$2,478
2021
$324
2020
$27
2019
$60
2018
$1,254
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
US Oncology Corporate, Inc.
$1,096
AstraZeneca Pharmaceuticals LP
$659
Genentech USA, Inc.
$212
Incyte Corporation
$190
Janssen Biotech, Inc.
$163
Eisai Inc.
$153
E.R. Squibb & Sons, L.L.C.
$150
Daiichi Sankyo Inc.
$146
Karyopharm Therapeutics Inc.
$124
Aveo Pharmaceuticals, Inc.
$118
GlaxoSmithKline, LLC.
$111
Agios Pharmaceuticals, Inc.
$90
Octapharma USA, Inc.
$86
PFIZER INC.
$81
TAIHO ONCOLOGY, INC.
$76
GENZYME CORPORATION
$76
Astellas Pharma US Inc
$75
Pharmacosmos Therapeutics Inc.
$65
SOBI, INC
$61
SpringWorks Therapeutics, Inc.
$59
ABBVIE INC.
$56
Rigel Pharmaceuticals, Inc.
$53
Novartis Pharmaceuticals Corporation
$53
Amneal Pharmaceuticals LLC
$50
Merck Sharp & Dohme LLC
$49
EMD Serono, Inc.
$47
Kite Pharma, Inc.
$44
Amgen Inc.
$43
Lilly USA, LLC
$42
Stemline Therapeutics Inc.
$41
Ipsen Biopharmaceuticals, Inc
$40
PUMA BIOTECHNOLOGY, INC.
$39
Cardinal Health 108 LLC
$36
Takeda Pharmaceuticals U.S.A., Inc.
$35
Eitan Medical North America, Inc.
$34
Alexion Pharmaceuticals, Inc.
$33
ARRAY BIOPHARMA INC
$33
Gilead Sciences, Inc.
$32
ADC Therapeutics America, Inc.
$31
Tempus AI, Inc
$30
Kyowa Kirin, Inc.
$30
RECORDATI_RARE_DISEASES_INC.
$28
Regeneron Healthcare Solutions, Inc.
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
PharmaEssentia USA Corporation
$26
Genmab U.S., Inc.
$25
Exelixis Inc.
$25
Apellis Pharmaceuticals, Inc.
$24
Deciphera Pharmaceuticals Inc.
$20
BeiGene USA, Inc.
$20
Fresenius Kabi USA, LLC
$19
Alnylam Pharmaceuticals Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$13
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2018-2024) ›
US Oncology Corporate, Inc.
$3,750
AstraZeneca Pharmaceuticals LP
$825
Novartis Pharmaceuticals Corporation
$617
Genentech USA, Inc.
$375
Amgen Inc.
$348
E.R. Squibb & Sons, L.L.C.
$346
Janssen Biotech, Inc.
$341
SOBI, INC
$304
Eisai Inc.
$288
GENZYME CORPORATION
$261
Seagen Inc.
$251
PFIZER INC.
$250
Incyte Corporation
$241
Daiichi Sankyo Inc.
$224
Lilly USA, LLC
$201
Astellas Pharma US Inc
$199
Karyopharm Therapeutics Inc.
$183
GlaxoSmithKline, LLC.
$172
EMD Serono, Inc.
$146
Aveo Pharmaceuticals, Inc.
$144
Merck Sharp & Dohme LLC
$142
Celgene Corporation
$129
Takeda Pharmaceuticals U.S.A., Inc.
$117
Merck Sharp & Dohme Corporation
$114
Agios Pharmaceuticals, Inc.
$104
EISAI INC.
$103
BeiGene USA, Inc.
$103
Pharmacosmos Therapeutics Inc.
$100
Gilead Sciences, Inc.
$95
Ipsen Biopharmaceuticals, Inc
$95
Kite Pharma, Inc.
$87
Octapharma USA, Inc.
$86
TAIHO ONCOLOGY, INC.
$76
Pharmacyclics LLC, An AbbVie Company
$72
ABBVIE INC.
$71
Janssen Products, LP
$65
Dendreon Pharmaceuticals LLC
$65
SpringWorks Therapeutics, Inc.
$59
Stemline Therapeutics Inc.
$57
Alexion Pharmaceuticals, Inc.
$54
Rigel Pharmaceuticals, Inc.
$53
Sobi, Inc
$53
RECORDATI_RARE_DISEASES_INC.
$52
Amneal Pharmaceuticals LLC
$50
PUMA BIOTECHNOLOGY, INC.
$39
Cardinal Health 108 LLC
$36
Alnylam Pharmaceuticals Inc.
$35
Eitan Medical North America, Inc.
$34
Coherus Biosciences Inc.
$33
ARRAY BIOPHARMA INC
$33
MorphoSys, US Inc.
$32
Bayer HealthCare Pharmaceuticals Inc.
$31
ADC Therapeutics America, Inc.
$31
Tempus AI, Inc
$30
Kyowa Kirin, Inc.
$30
Immunocore Limited
$29
AMAG Pharmaceuticals, Inc.
$29
Regeneron Healthcare Solutions, Inc.
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Pharmacyclics LLC, an AbbVie Company
$27
PharmaEssentia USA Corporation
$26
Genmab U.S., Inc.
$25
Exelixis Inc.
$25
Apellis Pharmaceuticals, Inc.
$24
JAZZ PHARMACEUTICALS INC.
$23
Spectrum Pharmaceuticals Inc.
$23
Acrotech Biopharma Inc.
$22
Teva Pharmaceuticals USA, Inc.
$22
Deciphera Pharmaceuticals Inc.
$20
Fresenius Kabi USA, LLC
$19
Seattle Genetics, Inc.
$19
Ethicon Inc.
$19
AbbVie, Inc.
$17
Integra LifeSciences Corporation
$15
Otsuka America Pharmaceutical, Inc.
$15
Bayer Healthcare Pharmaceuticals Inc.
$13
Secura Bio, Inc.
$13
Nestle HealthCare Nutrition Inc.
$11
Top 3 companies account for 42.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AUGTYRO · AVASTIN · Alecensa · Aranesp · BELEODAQ · BESREMI · BILAYER WOUND MATRIX (BWM) · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · COPIKTRA · COSELA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · EVENITY · Empaveli · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · Idhifa · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUPRON DEPOT · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · Monarch Platform · Neulasta · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PANHEMATIN · PANZYGA · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SOLIRIS · SPRYCEL · SYLVANT · Somatuline Depot · Stimufend · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TREANDA · TUKYSA · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Venclexta · XPOVIO · XTANDI · Xtandi · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
117
Per 100K population
9.2
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mobayed is a clinical cardiology specialist, with above-average Medicare volume (top 26% in MI), with low-engagement industry engagement in the top 14% of MI peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mobayed experienced with iron infusion (monoferric)?
Based on Medicare claims data, Dr. Mobayed performed 1,600 iron infusion (monoferric) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mobayed receive payments from pharmaceutical companies?
Yes. Dr. Mobayed received a total of $12,322 from 78 companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mobayed's costs compare to other hematology & oncology specialists in Rochester Hills?
Dr. Mobayed's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mobayed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Rochester Hills
Browse hematology & oncology specialists in Rochester Hills ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
US Oncology Corporate, Inc. Payments to Doctors
See all physicians who received payments from US Oncology Corporate, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology